Diactive-1: Scaled-up Personalized mHealth Program for Youth With Type 1 Diabetes

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age10-18
SponsorFundacion Miguel Servet

About this trial

The Diactive-1 project aims to establish the Diactive-1 mobile application as a clinical tool for managing type 1 diabetes in children and adolescents in several hospitals from Spain. The successful implementation of the app in new healthcare centers nationwide represents a key step toward the development of a comprehensive and scalable program. This approach seeks not only to optimize current patient care but also to democratize access to an innovative, evidence-based intervention that supports daily diabetes management.

In this new phase, the project will integrate the application into routine clinical care for patients with type 1 diabetes through the use of a simple handgrip strength measurement. A dedicated web platform (www.diactive.es) is being developed to allow clinicians to enter basic patient data, including handgrip strength, sex, and email address. Based on this information, the system will automatically generate a personalized download link for the Diactive-1 app, accompanied by tailored guidance and an initial fitness level classification (low, medium, or high) according to European reference values.

This process will define each user's baseline fitness level and facilitate the use of Diactive-1 as an integrated and individualized disease management tool. The ultimate goal is to strengthen clinical decision-making, improve patient engagement, and extend the benefits of digital health to a broader pediatric population living with type 1 diabetes.

Eligibility criteria

Qualifiers

Diagnosed with Type 1 Diabetes Mellitus (T1DM) for 6 months or longer (requiring >0.5 U/kg/day of insulin and having HbA1c >6%, i.e., not in the "honeymoon phase").

Receiving multiple daily injection (MDI) therapy or insulin pump therapy (CSII).

Signed informed consent authorizing legal participation in the research project (child/adolescent and parent(s)/legal guardian).

Availability to participate in the study using an m-Health application (Diactive-1) designed for the programming of muscle-bone strengthening physical exercise.

Disqualifiers

Comorbidities that limit the ability to engage in physical activity.

Lack of internet access when using the application, whether due to Wi-Fi, mobile data, or international roaming issues.

Absence of a mobile phone or tablet with an Android or iOS (Apple) operating system, or no family member willing to lend a device for each session using the application for study-related purposes.

Trial design

Treatments tested in this trial

  • Diactive-1

Treatment groups

158 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Fundacion Miguel Servet

Lead sponsor

Universidad Pública de Navarra

Collaborator

University of Valencia

Collaborator

Fundación Instituto de Investigación Sanitaria de Navarra

Collaborator